Europe accounted for a 19.3% share of global clinical trials activity in 2020, a decrease of 6.3% compared with a 25.6% average over the last ten-years, according to GlobalData.
In Europe, single country studies held a 70.8% share for all clinical trials in 2020, compared with the ten-year average of 69.2%. Multinational trials accounted for a 29.2% share in 2020 against an average of 30.8% in the last ten years.
Go deeper with GlobalData
- Embed this chart
Embed this chart into your website Copy and paste the code below into your website to display the chart.
Industry sponsored trials outnumber non-industry sponsored trials in Europe
Industry sponsored trials held a 62.5% share of all the clinical trials in Europe in 2020, a rise over their ten-year average of 61.6%. Non-industry sponsored trials accounted for a 37.5% share in 2020, down from an average of 38.4% in the last ten years.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData- Embed this chart
Embed this chart into your website Copy and paste the code below into your website to display the chart.
2020 industry sponsored clinical trials in Europe – Top therapy areas
Oncology was the leading therapy area for industry sponsored clinical trials in Europe in 2020 with a 25.3% share, down from its ten-year average of 26.2%.
Infectious Disease held a 19.9% share in 2020, up from its ten-year average of 10.8%.
In the third place was Central Nervous System with a 12.0% share in 2020, down from its ten-year average of 14.1%. Respiratory recorded a 10.4% share in 2020, a rise over its ten-year average of 8.0%.
With a share of 8.1% in 2020, Cardiovascular witnessed a drop over its ten-year average of 8.3%.
- Embed this chart
Embed this chart into your website Copy and paste the code below into your website to display the chart.
Non-industry sponsored clinical trials in Europe by top therapy areas
Infectious Disease was the leading therapy area for non-industry sponsored clinical trials in Europe in 2020 with a 31.6% share, up from a ten-year average of 9.7%.
In the second place was Central Nervous System with a 20.3% share in 2020, which represented a drop over a ten-year average of 24.5%.
With a share of 16.8% in 2020, Oncology witnessed a drop over its ten-year average of 18.6%. Respiratory held a 13.3% share in 2020, as against ten-year average of 4.9%.
Cardiovascular held a 10.9% share, which was down from ten-year average of 13.6%.
- Embed this chart
Embed this chart into your website Copy and paste the code below into your website to display the chart.
2020 clinical trials in Europe by phase
In terms of phases, Phase II trials led the industry sponsored clinical trials in Europe in 2020, with a share of 38.2%, marking a rise over a ten-year average of 35.9%.
Phase III trials stood next with a 26.2% share in 2020, which was even against a ten-year average of 26.3%.
In the third place was Phase I trials with a 25.7% share in 2020, up from its ten-year average of 22.6%.
Phase IV trials held an 9.9% share in 2020, with a 5.3% drop over its ten-year average of 15.2%.
- Embed this chart
Embed this chart into your website Copy and paste the code below into your website to display the chart.
For non-industry sponsored clinical trials in Europe, Phase II trials held a leading share of 50.0% in 2020, up from its ten-year average of 46.4%.
In the second place was Phase IV trials that held a 25.7% share in 2020 and saw a 6.9% drop over a ten-year average of 32.6%.
Phase III trials stood at 18.5% share, as against ten-year average of 14.6%.
Phase I trials held a 5.8% share in 2020, down from its ten-year average of 6.5%.
- Embed this chart
Embed this chart into your website Copy and paste the code below into your website to display the chart.
Methodology:
The clinical trials data used for the analyses were extracted from the Clinical Trials Database of GlobalData’s Pharma Intelligence Center. Clinical Trials are sourced from numerous government, non-government and company clinical trial registries worldwide alongside clinical research publications, scientific conferences, company websites, SEC filings and more. The information is gathered by a combination of automation and secondary research to ensure accuracy and validity. A small number of Phase 0, Phase I/II, Phase II/III, and Phase III/IV trials were combined with Phase I, Phase II, Phase III, and Phase IV trials, respectively.
